Cancer proteomics: Serum diagnostics for tumor marker discovery

Annals of the New York Academy of Sciences
Alex J Rai, Daniel W Chan

Abstract

Cancer proteomics is an exciting field that is witnessing many new developments in recent years. It is hoped that these advances will result in decreased cancer death rates, which have not declined dramatically in the last several decades. Some of the problems with current tumor markers include the lack of sensitivity and specificity, factors that prevent their use in population-based screening of disease. Thus, there is an urgent need to identify novel biomarkers that can faithfully detect the disease state. As we are now in the post-genome era, many opportunities have been created. Genomic sequence data are available for human, as well as several other species. We are now poised to mine these data and to determine the functions of the encoded proteins constituting the human genome. Proteomics affords this opportunity by providing enhanced procedures and tools for discovery and also a framework for understanding these components in terms of pathogenesis. New technologies and improvements in existing methodologies will allow for the rapid growth in the identification and characterization of peptides and proteins that are unique to various clinical states. This technology can be successfully applied to clinical specimens for the...Continue Reading

References

Feb 18, 1999·Molecular and Cellular Biology·S P GygiR Aebersold
Aug 2, 2000·Proceedings of the National Academy of Sciences of the United States of America·S P GygiR Aebersold
Feb 22, 2001·Science·J C VenterX Zhu
Mar 10, 2001·Nature·E S LanderUNKNOWN International Human Genome Sequencing Consortium
Feb 6, 2002·Current Opinion in Chemical Biology·Kathryn S LilleyPaul Dupree
Sep 5, 2002·Nature Reviews. Drug Discovery·Emanuel F PetricoinLance A Liotta
Sep 7, 2002·Cardiology in Review·Beth R Malasky, Joseph S Alpert
Oct 5, 2002·Disease Markers·W Hayes McDonald, John R Yates
Oct 12, 2002·Molecular & Cellular Proteomics : MCP·Richard S MorrisonTimothy D Veenstra
Nov 29, 2002·Archives of Pathology & Laboratory Medicine·Alex J RaiDaniel W Chan
Dec 6, 2002·Expert Review of Molecular Diagnostics·George L Wright
Dec 19, 2002·Molecular & Cellular Proteomics : MCP·N Leigh Anderson, Norman G Anderson
Mar 11, 2003·Technology in Cancer Research & Treatment·Tai-Tung Yip, Lee Lomas
Apr 23, 2003·Acta Biologica Hungarica·A MádiL Fésüs
May 21, 2003·Annals of Internal Medicine·Razelle KurzrockMoshe Talpaz
Oct 9, 2003·The Journal of Urology·O Harris FordJames L Mohler
Nov 5, 2003·Clinical Lung Cancer·Kiyoshi YanagisawaRichard M Caprioli

❮ Previous
Next ❯

Citations

Jan 11, 2005·The Journal of Pathology·Jayne L Dennis, Karin A Oien
Apr 27, 2005·Brain Research. Brain Research Reviews·Lap HoGiulio Maria Pasinetti
Mar 8, 2005·Drug Discovery Today·Travis DunckleyDietrich A Stephan
Sep 24, 2005·The British Journal of Nutrition·Dagmar FuchsHannelore Daniel
Sep 27, 2008·Acta Pharmacologica Sinica·Yan-jun HongSu Zeng
Jul 11, 2012·Sensors·Sofiya KolushevaAngel Porgador
Feb 6, 2014·BMC Clinical Pathology·Neomal S SandanayakeStephen P Pereira
Apr 12, 2007·Expert Review of Proteomics·María PardoNicole Zitzmann
Dec 17, 2008·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·Daren LiuLinhua Zhu
Apr 24, 2007·European Journal of Internal Medicine·Michael J Duffy
Dec 2, 2006·Urologic Oncology·Timothy J BradfordArul M Chinnaiyan
Jan 20, 2007·Cancer Science·Ashraf A Khalil, Peter James
Jul 30, 2008·Proteomics. Clinical Applications·Earle F BurgessJennifer A Pietenpol
Feb 22, 2005·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Tetsuya AdachiGozoh Tsujimoto
Nov 13, 2014·Cellular and Molecular Life Sciences : CMLS·Florian T UngerKerstin A David
Jul 16, 2005·Molecular & Cellular Proteomics : MCP·N Leigh Anderson
May 18, 2006·Proteomics·Agasanur K PrahaladJanet M Hock
Feb 1, 2008·Proteomics. Clinical Applications·Kothandaraman NarasimhanMahesh Choolani
Jun 15, 2006·Expert Review of Proteomics·Abdelali Haoudi, Halima Bensmail
Jun 26, 2009·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Shu-Yong XuXiao-Mei Lu
Mar 24, 2006·Southern Medical Journal·Kenneth E Hung, Daniel C Chung
May 28, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Georg Martin FiedlerJoachim Thiery

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.